These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 26368264)

  • 1. Heptadecanoylcarnitine (C17) a novel candidate biomarker for newborn screening of propionic and methylmalonic acidemias.
    Malvagia S; Haynes CA; Grisotto L; Ombrone D; Funghini S; Moretti E; McGreevy KS; Biggeri A; Guerrini R; Yahyaoui R; Garg U; Seeterlin M; Chace D; De Jesus VR; la Marca G
    Clin Chim Acta; 2015 Oct; 450():342-8. PubMed ID: 26368264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of 2-methylcitric acid in dried blood spots improves newborn screening for propionic and methylmalonic acidemias.
    Al-Dirbashi OY; McIntosh N; Chakraborty P
    J Med Screen; 2017 Jun; 24(2):58-61. PubMed ID: 27216769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newborn screening for propionic, methylmalonic acidemia and vitamin B12 deficiency. Analysis of 588,793 newborns.
    Martín-Rivada Á; Cambra Conejero A; Martín-Hernández E; Moráis López A; Bélanger-Quintana A; Cañedo Villarroya E; Quijada-Fraile P; Bellusci M; Chumillas Calzada S; Bergua Martínez A; Stanescu S; Martínez-Pardo Casanova M; Ruíz-Sala P; Ugarte M; Pérez González B; Pedrón-Giner C
    J Pediatr Endocrinol Metab; 2022 Oct; 35(10):1223-1231. PubMed ID: 36112821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of 3-hydroxypropionic acid, methylmalonic acid and methylcitric acid in dried blood spots: Second-tier LC-MS/MS assay for newborn screening of propionic acidemia, methylmalonic acidemias and combined remethylation disorders.
    Monostori P; Klinke G; Richter S; Baráth Á; Fingerhut R; Baumgartner MR; Kölker S; Hoffmann GF; Gramer G; Okun JG
    PLoS One; 2017; 12(9):e0184897. PubMed ID: 28915261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes after newborn screening for propionic and methylmalonic acidemia and homocystinurias.
    Reischl-Hajiabadi AT; Schnabel E; Gleich F; Mengler K; Lindner M; Burgard P; Posset R; Lommer-Steinhoff S; Grünert SC; Thimm E; Freisinger P; Hennermann JB; Krämer J; Gramer G; Lenz D; Christ S; Hörster F; Hoffmann GF; Garbade SF; Kölker S; Mütze U
    J Inherit Metab Dis; 2024 Jul; 47(4):674-689. PubMed ID: 38563533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Useful second-tier tests in expanded newborn screening of isovaleric acidemia and methylmalonic aciduria.
    Shigematsu Y; Hata I; Tajima G
    J Inherit Metab Dis; 2010 Oct; 33(Suppl 2):S283-8. PubMed ID: 20440648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences between acylcarnitine profiles in plasma and bloodspots.
    de Sain-van der Velden MG; Diekman EF; Jans JJ; van der Ham M; Prinsen BH; Visser G; Verhoeven-Duif NM
    Mol Genet Metab; 2013; 110(1-2):116-21. PubMed ID: 23639448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative acylcarnitine determination by UHPLC-MS/MS--Going beyond tandem MS acylcarnitine "profiles".
    Minkler PE; Stoll MS; Ingalls ST; Kerner J; Hoppel CL
    Mol Genet Metab; 2015 Dec; 116(4):231-41. PubMed ID: 26458767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid 2nd-tier test for measurement of 3-OH-propionic and methylmalonic acids on dried blood spots: reducing the false-positive rate for propionylcarnitine during expanded newborn screening by liquid chromatography-tandem mass spectrometry.
    la Marca G; Malvagia S; Pasquini E; Innocenti M; Donati MA; Zammarchi E
    Clin Chem; 2007 Jul; 53(7):1364-9. PubMed ID: 17510301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversity in the incidence and spectrum of organic acidemias, fatty acid oxidation disorders, and amino acid disorders in Asian countries: Selective screening vs. expanded newborn screening.
    Shibata N; Hasegawa Y; Yamada K; Kobayashi H; Purevsuren J; Yang Y; Dung VC; Khanh NN; Verma IC; Bijarnia-Mahay S; Lee DH; Niu DM; Hoffmann GF; Shigematsu Y; Fukao T; Fukuda S; Taketani T; Yamaguchi S
    Mol Genet Metab Rep; 2018 Sep; 16():5-10. PubMed ID: 29946514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Challenges Using a 2-Tier Strategy for Methylmalonic Acidurias: Data from 1.2 Million Dried Blood Spots.
    Weiss KJ; Röschinger W; Blessing H; Lotz-Havla AS; Schiergens KA; Maier EM
    Ann Nutr Metab; 2020; 76(4):268-276. PubMed ID: 32683363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A False-Positive Case of Methylmalonic Aciduria by Tandem Mass Spectrometry Newborn Screening Dependent on Maternal Malnutrition in Pregnancy.
    Rossi C; Cicalini I; Rizzo C; Zucchelli M; Consalvo A; Valentinuzzi S; Semeraro D; Gasparroni G; Brindisino P; Gazzolo D; Dionisi-Vici C; De Laurenzi V; Pieragostino D
    Int J Environ Res Public Health; 2020 May; 17(10):. PubMed ID: 32443888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma methylcitric acid and its correlations with other disease biomarkers: The impact in the follow up of patients with propionic and methylmalonic acidemia.
    Maines E; Catesini G; Boenzi S; Mosca A; Candusso M; Dello Strologo L; Martinelli D; Maiorana A; Liguori A; Olivieri G; Taurisano R; Piemonte F; Rizzo C; Spada M; Dionisi-Vici C
    J Inherit Metab Dis; 2020 Nov; 43(6):1173-1185. PubMed ID: 32681732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective evaluation of the Dutch pre-newborn screening cohort for propionic acidemia and isolated methylmalonic acidemia: What to aim, expect, and evaluate from newborn screening?
    Haijes HA; Molema F; Langeveld M; Janssen MC; Bosch AM; van Spronsen F; Mulder MF; Verhoeven-Duif NM; Jans JJM; van der Ploeg AT; Wagenmakers MA; Rubio-Gozalbo ME; Brouwers MCGJ; de Vries MC; Langendonk JG; Williams M; van Hasselt PM
    J Inherit Metab Dis; 2020 May; 43(3):424-437. PubMed ID: 31828787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal Macrosomia is an Interfering Factor for Analytes on the Colorado State Newborn Screen.
    Wright EL; Baker PR
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 32126138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newborn screening and early biochemical follow-up in combined methylmalonic aciduria and homocystinuria, cblC type, and utility of methionine as a secondary screening analyte.
    Weisfeld-Adams JD; Morrissey MA; Kirmse BM; Salveson BR; Wasserstein MP; McGuire PJ; Sunny S; Cohen-Pfeffer JL; Yu C; Caggana M; Diaz GA
    Mol Genet Metab; 2010 Feb; 99(2):116-23. PubMed ID: 19836982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic challenges of aminoacidopathies and organic acidemias in a developing country: a twelve-year experience.
    Karam PE; Habbal MZ; Mikati MA; Zaatari GE; Cortas NK; Daher RT
    Clin Biochem; 2013 Dec; 46(18):1787-92. PubMed ID: 23994778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of potential interferents of methylmalonic acid: A previously unrecognized pitfall in clinical diagnostics and newborn screening.
    Monostori P; Godejohann M; Janda J; Galla Z; Rácz G; Klinke G; Szatmári I; Zsidegh P; Kohlmüller D; Kölker S; Hoffmann GF; Gramer G; Okun JG
    Clin Biochem; 2023 Jan; 111():72-80. PubMed ID: 36202155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Outcomes of patients with combined methylmalonic acidemia and homocystinuria after treatment].
    Huang Z; Han LS; Ye J; Qiu WJ; Zhang HW; Gao XL; Wang Y; Ji WJ; Li XY; Gu XF
    Zhonghua Er Ke Za Zhi; 2013 Mar; 51(3):194-8. PubMed ID: 23751581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The markers of the organic acidemias and their ratios in healthy neonates in Serbian population.
    Beletić A; Tijanić A; Chrastina P; Nikolić T; Stefanović A; Stanković S
    Drug Metab Pers Ther; 2022 Sep; 37(3):271-275. PubMed ID: 35254746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.